Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Moodys
AstraZeneca
UBS
Harvard Business School
Queensland Health
Deloitte
Cerilliant
Merck

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,068,859

« Back to Dashboard

Summary for Patent: 6,068,859
Title: Controlled-release dosage forms of Azithromycin
Abstract:A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
Inventor(s): Curatolo; William J. (Niantic, CT), Friedman; Hylar L. (Brattleboro, VT), Korsmeyer; Richard W. (Old Lyme, CT), LeMott; Steven R. (East Lyme, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:08/727,634
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,068,859
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Device; Use; Process; Formulation;

Drugs Protected by US Patent 6,068,859

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,068,859

PCT Information
PCT FiledApril 13, 1995PCT Application Number:PCT/IB94/00264
PCT Publication Date:November 16, 1995PCT Publication Number: WO95/30422

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Medtronic
Teva
McKinsey
Queensland Health
Express Scripts
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.